MAPK3’s involvement in cell proliferation and survival, alongside PIK3CA and mTOR’s roles in metabolic regulation and tumor progression, underlines their contribution to breast cancer pathophysiology, particularly in aggressive subtypes like TNBC and HER2-positive cancers. The gene discussed is ERBB2; the disease is breast carcinoma.